Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,973 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Risk of cardiovascular disease and total mortality in adults with type 1 diabetes: Scottish registry linkage study.
Livingstone SJ, Looker HC, Hothersall EJ, Wild SH, Lindsay RS, Chalmers J, Cleland S, Leese GP, McKnight J, Morris AD, Pearson DW, Peden NR, Petrie JR, Philip S, Sattar N, Sullivan F, Colhoun HM. Livingstone SJ, et al. Among authors: chalmers j. PLoS Med. 2012;9(10):e1001321. doi: 10.1371/journal.pmed.1001321. Epub 2012 Oct 2. PLoS Med. 2012. PMID: 23055834 Free PMC article.
The relative and combined ability of high-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic peptide to predict cardiovascular events and death in patients with type 2 diabetes.
Hillis GS, Welsh P, Chalmers J, Perkovic V, Chow CK, Li Q, Jun M, Neal B, Zoungas S, Poulter N, Mancia G, Williams B, Sattar N, Woodward M. Hillis GS, et al. Among authors: chalmers j. Diabetes Care. 2014;37(1):295-303. doi: 10.2337/dc13-1165. Epub 2013 Oct 2. Diabetes Care. 2014. PMID: 24089534 Free article.
Response to comment on Hillis et al. The relative and combined ability of high-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic Peptide to predict cardiovascular events and death in patients with type 2 diabetes. Diabetes care 2014;37:295-303.
Hillis GS, Welsh P, Chalmers J, Woodward M, Sattar N. Hillis GS, et al. Among authors: chalmers j. Diabetes Care. 2014 Jun;37(6):e154. doi: 10.2337/dc14-0485. Diabetes Care. 2014. PMID: 24855181 No abstract available.
Predicting the effects of blood pressure-lowering treatment on major cardiovascular events for individual patients with type 2 diabetes mellitus: results from Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation.
van der Leeuw J, Visseren FL, Woodward M, Zoungas S, Kengne AP, van der Graaf Y, Glasziou P, Hamet P, MacMahon S, Poulter N, Grobbee DE, Chalmers J. van der Leeuw J, et al. Among authors: chalmers j. Hypertension. 2015 Jan;65(1):115-21. doi: 10.1161/HYPERTENSIONAHA.114.04421. Epub 2014 Oct 13. Hypertension. 2015. PMID: 25312436 Clinical Trial.
Cohort Profile: Scottish Diabetes Research Network Type 1 Bioresource Study (SDRNT1BIO).
Akbar T, McGurnaghan S, Palmer CNA, Livingstone SJ, Petrie J, Chalmers J, Lindsay RS, McKnight JA, Pearson DWM, Patrick AW, Walker J, Looker HC, Colhoun HM. Akbar T, et al. Among authors: chalmers j. Int J Epidemiol. 2017 Jun 1;46(3):796-796i. doi: 10.1093/ije/dyw152. Int J Epidemiol. 2017. PMID: 28338705 Free PMC article. No abstract available.
Prognostic Value of Variability in Systolic Blood Pressure Related to Vascular Events and Premature Death in Type 2 Diabetes Mellitus: The ADVANCE-ON Study.
Ohkuma T, Woodward M, Jun M, Muntner P, Hata J, Colagiuri S, Harrap S, Mancia G, Poulter N, Williams B, Rothwell P, Chalmers J; ADVANCE Collaborative Group. Ohkuma T, et al. Among authors: chalmers j. Hypertension. 2017 Aug;70(2):461-468. doi: 10.1161/HYPERTENSIONAHA.117.09359. Epub 2017 Jun 5. Hypertension. 2017. PMID: 28584014 Clinical Trial.
N-Glycan Profile and Kidney Disease in Type 1 Diabetes.
Bermingham ML, Colombo M, McGurnaghan SJ, Blackbourn LAK, Vučković F, Pučić Baković M, Trbojević-Akmačić I, Lauc G, Agakov F, Agakova AS, Hayward C, Klarić L, Palmer CNA, Petrie JR, Chalmers J, Collier A, Green F, Lindsay RS, Macrury S, McKnight JA, Patrick AW, Thekkepat S, Gornik O, McKeigue PM, Colhoun HM; SDRN Type 1 Bioresource Investigators. Bermingham ML, et al. Among authors: chalmers j. Diabetes Care. 2018 Jan;41(1):79-87. doi: 10.2337/dc17-1042. Epub 2017 Nov 16. Diabetes Care. 2018. PMID: 29146600
Blood pressure-lowering treatment strategies based on cardiovascular risk versus blood pressure: A meta-analysis of individual participant data.
Karmali KN, Lloyd-Jones DM, van der Leeuw J, Goff DC Jr, Yusuf S, Zanchetti A, Glasziou P, Jackson R, Woodward M, Rodgers A, Neal BC, Berge E, Teo K, Davis BR, Chalmers J, Pepine C, Rahimi K, Sundström J; Blood Pressure Lowering Treatment Trialists’ Collaboration. Karmali KN, et al. Among authors: chalmers j. PLoS Med. 2018 Mar 20;15(3):e1002538. doi: 10.1371/journal.pmed.1002538. eCollection 2018 Mar. PLoS Med. 2018. PMID: 29558462 Free PMC article.
Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE trial.
Welsh P, Rankin N, Li Q, Mark PB, Würtz P, Ala-Korpela M, Marre M, Poulter N, Hamet P, Chalmers J, Woodward M, Sattar N. Welsh P, et al. Among authors: chalmers j. Diabetologia. 2018 Jul;61(7):1581-1591. doi: 10.1007/s00125-018-4619-x. Epub 2018 May 4. Diabetologia. 2018. PMID: 29728717 Free PMC article. Clinical Trial.
1,973 results